Colorado Choice/SLVHMO Pharmacy Guide 700 Main Street, Suite 100 Alamosa, CO 81101 Phone: (719) 589-3696 Fax: (719) 589-4995
Communication of Information
To ensure rapid patient care, effective communica-
Telephone
tion of information between prescribing physicians
and Prescription Solutions Prior Authorization
Team members is required. You need to provide
complete clinical information when requesting prior
authorizations. Information required for prior autho-
option “2” anytime after the first 20
Patient’s pertinent medical test results-
Requests for prior authorization with incomplete or
missing information will not be considered com-
plete until all information is provided. Faxed re-
quests with incomplete or missing information will
ing/Additional Information Fax form and, if applica-
ble, the Drug Specific Form. Phone requests that
cannot be completed during the initial call because
of incomplete or missing information will be given a
telephone number to call when the information is
available, or, if applicable, a fax number to fax re-
able, you will be asked to phone and/or fax back the in-
Prior Auth Fax Process
4. Locate and record the missing and/or additional information on
fax form(s) received from Prescription Solutions Prior Authoriza-
1. Ensure all relevant member and clinical information is
5. Call or fax additional information to RxSolutions Prior Authoriza-
2. Fax the request form to Prescription Solutions Prior Au-
tion Department using the numbers indicated on the Request for
Missing/Additional Information form within 48 hours.
3. If fax is incomplete or additional information is required,
6. Decisions are rendered upon receipt of all information and writ-
ten communication of the decision will be faxed w/in 48 hours.
Decision on requests pending information will be rendered not
If additional information is needed, follow next steps:
exceeding 48 hours from receipt of all information.
DRUGS NEE DI NG A P R I O R AUT HO RIZ AT I O N Excluded Drugs INJECTABLE AFTER HOURS POLICY Prescription Solutions
4. If the requested injectable is not listen on
Colorado Choice/SLVHMO will cover certain
the after hours injectable drug list, have
injectable medications at a contracted retail
the member call the prescribing physician
pharmacy if a Prior Authorization has been
receives a prescription for an injectable me-
Name of Injectable Maximum supply
dication after hours and a prior authorization
Anti-inhibitor complexes (Autoplex T, NovoSe-
has not been obtained, the following proce-
dure would apply to ensure prompt appropri-
DDAVP -5 days Local Pharmacies may
Factor VIII Products (Alphanate, Koate-DVI,
member presents a prescription for an inject-
supply injectables in an
able medication from the list below and Pre-
urgent situation if they
scription Solutions Clinical Pharmacy De-
have them available.
partment is not available the pharmacist
1. Fill the prescription for no more than the
Interferon-Alpha Products (Alferon-N, Intron-N,
quantity specified in the following chart.
2. Call Prescription Solutions Help Desk at
(800) 788-7871 during the next working Gentiva Health Services day for a one-time override and to
3. Notify the physician’s office of the need
for Prior Authorization if the prescription
calls for duration of therapy greater than
5 days. Please have physician call Prior Authorization at (800) 711-4555.
PRODIGY Quick Reference Guide Asymptomatic bacteriuria and UTI in Urinary tract infection (UTI) occurs when micro- pregnant women organisms infect the urine, urethra, bladder, or kidney. Lower UTI refers to cystitis with or without urethritis. This covers the management of bacteriuria in a pregnant woman with a Based on PRODIGY guidance last revised in July 2005. normal
RIASSUNTO DELLE CARATTERISTICHE DEL PRODOTTO 1 Denominazione del medicinale TERAZOSINA ABC 2 mg compresse TERAZOSINA ABC 5 mg compresse 2 Composizione qualitativa e quantitativa Ogni Compressa divisibile da 2 mg contiene 2,374 mg di terazosina cloridrato di drata equivalenti a 2 mg di terazosina. Ogni Compressa divisibile da 5 mg contiene 5,935 mg di terazosina cloridrato di drata equivalenti a